In accordance with previous findings40, we show that ormeloxifene downregulates the PI3K-Akt pathway in cervical cancer cells as shown by decreased expression levels of PI3K, Akt and pAkt (Fig. 3A bottom). Here, AKT1 is linked to cervical carcinoma.